At the news
? BEARISHIMPACT 7/10 424B5 filed May 4, 2026 at 06:37 ET
Cabaletta Bio is selling 51,725,000 shares of common stock at $2.90 per share in a dilutive follow-on offering, raising approximately $141 million in net proceeds. The offering represents a ~51% increase in shares outstanding (from ~100.5M to ~152.2M), creating immediate dilution of $1.30 per share for new investors. Proceeds will fund expanded clinical development of its lead CAR-T candidate rese-cel and manufacturing scale-up, extending cash runway into mid-2027.
- Offering of 51,725,000 shares at $2.90 per share, raising $150M gross / ~$141M net proceeds
- Shares outstanding will increase from ~100.5M to ~152.2M, a ~51% dilution
- Immediate dilution of $1.30 per share for new investors (offering price $2.90 vs. as-adjusted book value $1.60)
- Preliminary cash balance of ~$117M as of March 31, 2026; pro-forma cash ~$252.6M after offering
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access